Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWS

  • STATUS
    Not Recruiting
  • End date
    Jun 1, 2024
  • participants needed
    30
  • sponsor
    Pfizer
Updated on 5 March 2022

Summary

This is a multicenter, open label, multi cohort study to evaluate the efficacy and safety of somatropin in a cohort of Japanese participants with PWS.

Details
Condition Obesity, Prader-Willi Syndrome
Treatment somatropin - GH naïve pediatric cohort, somatropin - GH treated cohort, somatropin - adult cohort
Clinical Study IdentifierNCT04697381
SponsorPfizer
Last Modified on5 March 2022

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note